MetaCap

Janux Therapeutics Insider Trades

NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.08-0.21 (-2.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
10 · $457.07K
Shares bought / sold
0 / 28.46K
Net activity
Net selling $457,074

Janux Therapeutics insider activity

Over the last 12 months, Janux Therapeutics insiders reported 27 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $457,074 worth of stock, for net insider selling of $457,074. The largest seller was Meyer Andrew Hollman, with $135,728 in reported sales.

The most recent filing shows Campbell David Alan (President and CEO) reporting a transaction in 123,840 shares on Jul 31, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put JANX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

JANX insider transactions

Janux Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jul 31, 2026Campbell David AlanPresident and CEOGift123,840—Form 4
Jul 8, 2026Campbell David AlanPresident and CEOOption exercise7,000$29.47KForm 4
Jun 11, 2026Simson JakeDirectorAward5,500—Form 4
Jun 11, 2026Barrett Ronald WDirectorAward5,500—Form 4
Jun 11, 2026CAPPS VICKIE LDirectorAward5,500—Form 4
Jun 11, 2026DOBMEIER ERICDirectorAward5,500—Form 4
Jun 11, 2026Hernday NatashaDirectorAward5,500—Form 4
Jun 11, 2026Kung WinstonDirectorAward5,500—Form 4
Jun 11, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorAward5,500—Form 4
Jun 2, 2026Doyle Janeen NoelChief Corp. & Bus. Dev. OfcrSale4,059$56.94KForm 4
May 11, 2026Dobek MariaVice President, AccountingSale2,038$28.88KForm 4
Feb 2, 2026Go WilliamChief Medical OfficerAward44,000—Form 4
Jan 2, 2026Doyle Janeen NoelChief Corp. & Bus. Dev. OfcrAward36,000—Form 4
Jan 2, 2026McIver ZachariahChief Medical OfficerAward29,000—Form 4
Jan 2, 2026McIver ZachariahChief Medical OfficerSale2,714$37.26KForm 4
Jan 2, 2026Campbell David AlanPresident and CEOAward96,600—Form 4
Jan 2, 2026Campbell David AlanPresident and CEOSale8,072$110.83KForm 4
Jan 2, 2026Dobek MariaVice President, AccountingAward18,935—Form 4
Jan 2, 2026Dobek MariaVice President, AccountingSale1,462$20.07KForm 4
Jan 2, 2026Winter Charles M.Chief Technical OfficerAward28,600—Form 4
Jan 2, 2026Winter Charles M.Chief Technical OfficerSale2,401$32.97KForm 4
Jan 2, 2026DiRaimondo ThomasChief Scientific OfficerAward31,400—Form 4
Jan 2, 2026DiRaimondo ThomasChief Scientific OfficerSale2,505$34.39KForm 4
Jan 2, 2026Meyer Andrew HollmanChief Business OfficerSale1,879$25.80KForm 4
Dec 1, 2025Meyer Andrew HollmanChief Business OfficerSale633$21.22KForm 4
Dec 1, 2025Meyer Andrew HollmanChief Business OfficerSale2,700$88.71KForm 4
Dec 1, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,333$35.30KForm 4
Nov 14, 2025Meyer Andrew HollmanChief Business OfficerSale3,333$99.99KForm 4
Nov 14, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,333$35.30KForm 4
Oct 28, 2025Meyer Andrew HollmanChief Business OfficerSale16,665$500.99KForm 4
Oct 28, 2025Meyer Andrew HollmanChief Business OfficerOption exercise6,666$70.59KForm 4
Oct 28, 2025Meyer Andrew HollmanChief Business OfficerOption exercise9,999$42.10KForm 4
Jun 11, 2025Hernday NatashaDirectorAward3,750—Form 4
Jun 11, 2025Gujrathi SheilaDirectorAward3,750—Form 4
Jun 11, 2025DOBMEIER ERICDirectorAward3,750—Form 4
Jun 11, 2025Kung WinstonDirectorAward3,750—Form 4
Jun 11, 2025Simson JakeDirectorAward3,750—Form 4
Jun 11, 2025McNulty Alana B.DirectorAward3,750—Form 4
Jun 11, 2025Barrett Ronald WDirectorAward3,750—Form 4
Jun 11, 2025CAPPS VICKIE LDirectorAward3,750—Form 4
Jun 11, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorAward3,750—Form 4
Jun 2, 2025Doyle Janeen NoelChief Corp. & Bus. Dev. OfcrAward44,000—Form 4
May 1, 2025Meyer Andrew HollmanChief Business OfficerSale400$13.04KForm 4
May 1, 2025Meyer Andrew HollmanChief Business OfficerSale2,933$93.70KForm 4
May 1, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,333$14.03KForm 4
Apr 21, 2025Meyer Andrew HollmanChief Business OfficerSale3,334$100.02KForm 4
Apr 21, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,334$14.04KForm 4
Mar 7, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy110,206$3.42MForm 4
Mar 6, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy372,093$11.45MForm 4
Mar 5, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy37,455$1.17MForm 4
Mar 5, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy304,287$9.30MForm 4
Mar 3, 2025Meyer Andrew HollmanChief Business OfficerSale901$29.60KForm 4
Mar 3, 2025Meyer Andrew HollmanChief Business OfficerSale2,433$77.58KForm 4
Mar 3, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,334$14.04KForm 4
Feb 3, 2025Meyer Andrew HollmanChief Business OfficerSale100$4.36KForm 4
Feb 3, 2025Meyer Andrew HollmanChief Business OfficerSale816$34.90KForm 4
Feb 3, 2025Meyer Andrew HollmanChief Business OfficerSale2,418$101.74KForm 4
Feb 3, 2025Meyer Andrew HollmanChief Business OfficerOption exercise3,334$14.04KForm 4
Jan 7, 2025Campbell David AlanPresident and CEOSale5,000$300.00KForm 4
Jan 2, 2025Winter Charles M.Chief Technical OfficerAward23,000—Form 4
Jan 2, 2025McIver ZachariahChief Medical OfficerAward26,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related